NCT00725218

Flurbiprofen Axetil for Uterine Contraction Pain

Phase IV Study of Flurbiprofen Axetil for Uterine Contraction Pain After Abortion

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 97 (actual)
• Sponsor: Nanjing Medical University · Academic / Other
• Sex: Female
• Age: 19 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress the uterine contraction pain after abortion effectively.

Conditions

• Postoperative Pain

Interventions

Type	Name	Description
DRUG	Saline	Saline 5 ml injection 10 min prior to propofol administration.
DRUG	Flurbiprofen Axetil	Flurbiprofen Axetil 50 mg in 5 ml injection 10min prior to propofol administration.

Timeline

• Start date: 2008-05-01
• Primary completion: 2008-08-01
• Completion: 2008-08-01
• First posted: 2008-07-30
• Last updated: 2008-08-06

Locations

1 site across 1 country: China